Xebio Holdings Co., Ltd. (TYO:8281)
Japan · Delayed Price · Currency is JPY 1,111.00
+1.00 (0.09%)
Feb 13, 2026, 3:30 PM JST
Xebio Holdings Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 249,729 | 250,603 | 242,433 | 239,293 | 223,282 | 202,438 | |
Revenue Growth (YoY) | 0.88% | 3.37% | 1.31% | 7.17% | 10.30% | -10.15% |
Cost of Revenue | 152,914 | 152,931 | 149,546 | 147,519 | 136,228 | 123,618 |
Gross Profit | 96,815 | 97,672 | 92,887 | 91,774 | 87,054 | 78,820 |
Selling, General & Admin | 86,173 | 84,898 | 84,221 | 79,900 | 78,439 | 72,401 |
Operating Expenses | 91,940 | 90,665 | 88,682 | 83,446 | 82,054 | 76,055 |
Operating Income | 4,875 | 7,007 | 4,205 | 8,328 | 5,000 | 2,765 |
Interest Expense | -84 | -105 | -104 | -64 | -120 | -124 |
Interest & Investment Income | 66 | 39 | 98 | 87 | 59 | 54 |
Currency Exchange Gain (Loss) | 703 | 197 | 555 | 323 | 559 | 150 |
Other Non Operating Income (Expenses) | 667 | 480 | 650 | 566 | 2,353 | 1,496 |
EBT Excluding Unusual Items | 6,227 | 7,618 | 5,404 | 9,240 | 7,851 | 4,341 |
Gain (Loss) on Sale of Investments | -43 | -613 | 4 | - | -19 | 8 |
Gain (Loss) on Sale of Assets | -2,382 | -10 | 2 | 5 | -13 | 1,380 |
Asset Writedown | -3,789 | -3,840 | -724 | -777 | -1,583 | -2,847 |
Other Unusual Items | -103 | -78 | -166 | 366 | -22 | 212 |
Pretax Income | -90 | 3,077 | 4,520 | 8,834 | 6,214 | 3,094 |
Income Tax Expense | 899 | 2,098 | 1,789 | 3,241 | 2,361 | 2,681 |
Earnings From Continuing Operations | -989 | 979 | 2,731 | 5,593 | 3,853 | 413 |
Minority Interest in Earnings | 110 | -8 | -139 | -196 | -17 | -1 |
Net Income | -879 | 971 | 2,592 | 5,397 | 3,836 | 412 |
Net Income to Common | -879 | 971 | 2,592 | 5,397 | 3,836 | 412 |
Net Income Growth | - | -62.54% | -51.97% | 40.69% | 831.07% | 0.98% |
Shares Outstanding (Basic) | 42 | 43 | 44 | 44 | 44 | 44 |
Shares Outstanding (Diluted) | 42 | 43 | 44 | 44 | 44 | 44 |
Shares Change (YoY) | -5.43% | -2.66% | 0.11% | 0.04% | 0.07% | 0.05% |
EPS (Basic) | -21.02 | 22.60 | 58.63 | 122.07 | 86.77 | 9.32 |
EPS (Diluted) | -21.02 | 22.46 | 58.31 | 121.58 | 86.44 | 9.29 |
EPS Growth | - | -61.48% | -52.04% | 40.65% | 830.46% | 0.98% |
Free Cash Flow | 2,460 | 5,349 | -51 | 3,663 | -1,286 | 22,973 |
Free Cash Flow Per Share | 58.83 | 123.64 | -1.15 | 82.51 | -28.98 | 518.02 |
Dividend Per Share | 35.000 | 32.500 | 30.000 | 30.000 | 30.000 | 30.000 |
Dividend Growth | 16.67% | 8.33% | - | - | - | -7.69% |
Gross Margin | 38.77% | 38.98% | 38.31% | 38.35% | 38.99% | 38.93% |
Operating Margin | 1.95% | 2.80% | 1.73% | 3.48% | 2.24% | 1.37% |
Profit Margin | -0.35% | 0.39% | 1.07% | 2.25% | 1.72% | 0.20% |
Free Cash Flow Margin | 0.98% | 2.13% | -0.02% | 1.53% | -0.58% | 11.35% |
EBITDA | 11,122 | 12,937 | 9,297 | 12,395 | 9,247 | 7,224 |
EBITDA Margin | 4.45% | 5.16% | 3.84% | 5.18% | 4.14% | 3.57% |
D&A For EBITDA | 6,247 | 5,930 | 5,092 | 4,067 | 4,247 | 4,459 |
EBIT | 4,875 | 7,007 | 4,205 | 8,328 | 5,000 | 2,765 |
EBIT Margin | 1.95% | 2.80% | 1.73% | 3.48% | 2.24% | 1.37% |
Effective Tax Rate | - | 68.18% | 39.58% | 36.69% | 38.00% | 86.65% |
Advertising Expenses | - | 6,882 | 7,401 | 6,372 | 6,194 | 5,001 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.